Jindal Vineet R. 4
4 · Reneo Pharmaceuticals, Inc. · Filed Aug 26, 2021
Insider Transaction Report
Form 4
Jindal Vineet R.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-08-25$7.44/sh+5,000$37,177→ 5,000 total
Footnotes (1)
- [F1]The weighted average purchase price for the transaction was $7.4353. The shares were purchased at a range of prices between $7.39 and $7.47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.